34 participants
VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-21
- Start Date:
- 2017-09-15
- Completion:
- 2023-08-29
Conditions
- Metastatic Endometrial Carcinoma
- Recurrent Endometrial Adenocarcinoma
- Recurrent Endometrial Carcinoma
- Recurrent Endometrial Clear Cell Adenocarcinoma
- Recurrent Endometrial Endometrioid Adenocarcinoma
- Recurrent Endometrial Mixed Cell Adenocarcinoma
- Recurrent Endometrial Serous Adenocarcinoma
- Recurrent Endometrial Undifferentiated Carcinoma
- Recurrent Uterine Corpus Carcinosarcoma
- Stage IV Uterine Corpus Cancer AJCC v7
Interventions
- PROCEDURE
- OTHER
- BIOLOGICAL
- DRUG